Literature DB >> 7813690

Knowledge, attitudes and beliefs of European injecting drug users concerning preventive measures for HIV.

S C Richardson1, G Papaevangelou, R Ancelle-Park.   

Abstract

Strategies for controlling the HIV epidemic include education and information campaigns for intravenous drug users (IDUs), as for all high-risk groups, and the provision of various public health measures and treatment. These can only be effective if the IDU is aware of them and has a favourable image of them. A study of 2330 IDUs in 12 European countries recorded awareness and opinions of various categories of measures and institutions. Of all measures, those mentioned most often related to availability of new injecting equipment; specifically unrestricted sales in pharmacies and needle exchanges, which were also thought to be more useful than anything else. Prompted awareness of rehabilitative institutions was well over 90% in most countries, but up to a quarter of IDUs did not trust them and up to one fifth did not think that they were useful. There appears to be a general need for more effective communication with IDUs to improve the image of the services available.

Entities:  

Mesh:

Year:  1994        PMID: 7813690     DOI: 10.1007/bf01730362

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  AIDS-related behavior and attitudes among i.v. drug users in Greece.

Authors:  A Kokkevi; S Alevizou; Y Arvanitis; J Liappas; C Stefanis
Journal:  Int J Addict       Date:  1992-01

2.  Intravenous drug users and AIDS: risk behaviors.

Authors:  R Booth; S Koester; J T Brewster; W W Weibel; R B Fritz
Journal:  Am J Drug Alcohol Abuse       Date:  1991-09       Impact factor: 3.829

Review 3.  Transmission of the human immunodeficiency virus.

Authors:  G H Friedland; R S Klein
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

4.  HTLV-III antibodies in drug addicts in Spain.

Authors:  J M Rodrigo; M A Serra; E Aguilar; J A del Olmo; V Gimeno; L Aparisi
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

5.  Rapid spread of HTLV-III infection among drug addicts in Italy.

Authors:  G Angarano; G Pastore; L Monno; T Santantonio; N Luchena; O Schiraldi
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

6.  Factors associated with HIV seropositivity in European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.

Authors:  C Richardson; R Ancelle-Park; G Papaevangelou
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

7.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.

Authors:  J C Desenclos; G Papaevangelou; R Ancelle-Park
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

8.  HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.

Authors:  K I Käll; R G Olin
Journal:  AIDS       Date:  1990-02       Impact factor: 4.177

9.  Trends in HIV infection among intravenous drug users in Innsbruck, Austria.

Authors:  R Zangerle; D Fuchs; H Rössler; G Reibnegger; Y Riemer; S H Weiss; P Fritsch; H Wachter
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

Review 10.  Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.

Authors:  P W Brickner; R A Torres; M Barnes; R G Newman; D C Des Jarlais; D P Whalen; D E Rogers
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

View more
  3 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Trends in HIV seroprevalence, AIDS and prevention policy among intravenous drug users and men who have sex with men, before and after 1990 in Austria.

Authors:  F Piribauer; W Duer
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

3.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.